Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 6 August 2014, 13:50 HKT/SGT
Share:
    

Source: Pertanika Journal
Can probiotics reduce the severity of C. difficile infections?

Selangor, Malaysia, Aug 6, 2014 - (ACN Newswire) - Probiotics have shown promise for treating patients with recurrent Clostridium difficile infections. However, their safety and quality control requires further study - especially in immunocompromised patients, concludes a review paper published in the Pertanika Journal of Science and Technology.

The paper, by Y. Y. Loong and colleagues at the Universiti Putra Malysia, examines the epidemiology, immune responses, symptoms and diagnosis of C. difficile infections (CDI). It also discusses antibiotic susceptibility, CDI recurrences, probiotics and other alternative treatments.

C. difficile is an opportunistic pathogen found in the intestines of approximately 3% of healthy adults and 40% of infants. The bacterium causes a spectrum of diseases in humans, ranging from mild to severe. Infection rates are particularly high in North America and European countries. Studies have shown that this bacterium is responsible for 10-25% of antibiotic-associated diarrhoea cases, 50-75% of antibiotic-associated colitis cases, and 90-100% of antibiotic-associated pseudomembranous colitis, respectively.

The antibiotics metronidazole and vancomycin have been recommended as the treatments of choice for C. difficile infections since the 1990s. However, there is a high risk that CDI will recur after several days of antibiotic administration. Metronidazole-resistant C. difficile also needs to be considered during treatment. Thus, a re-evaluation of the use of metronidazole as the first-line treatment is needed in areas with high resistant rates, comment Y. Y. Loong and colleagues.

Probiotics - beneficial microorganisms deliberately introduced into the body - have been used in some patients as an adjunct treatment with some success. However, a detailed investigation on the use of probiotics for infected patients is still needed to determine their real efficacy, recommend the authors. In addition, scientists need to explore new types of probiotics. "This will enable physicians to choose from a wider range of probiotics and develop a better combination to be used as adjunct treatments."

For more information about each research, please contact:

Y. Y. Loong
Department of Medicine, Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
43400, Serdang, Selangor, Malaysia
Email: loongyy@yahoo.com
Tel: +603 8947 2729; Mobile: +6016 285 2590.

About Pertanika Journal of Science & Technology (JST)

Pertanika Journal of Science & Technology (JST) is published by Universiti Putra Malaysia in English and is open to authors around the world regardless of nationality. Currently, it is published twice a year in January and July. Other Pertanika series include Pertanika Journal of Tropical Agricultural Science (JTAS), and Pertanika Journal of Social Sciences & Humanities (JSSH).

Pertanika Journal of Science & Technology aims to provide a forum for high quality research related to science and engineering research. Areas relevant to the scope of the journal include: bioinformatics, bioscience, biotechnology and bio-molecular sciences, chemistry, computer science, ecology, engineering, engineering design, environmental control and management, mathematics and statistics, medicine and health sciences, nanotechnology, physics, safety and emergency management, and related fields of study.

Website: http://www.pertanika.upm.edu.my/

The paper is available from this link: http://bit.ly/1opXCLn

For more information about the journal, contact:

The Chief Executive Editor (UPM Journals)
Head, Journal Division, UPM Press
Office of the Deputy Vice Chancellor (R&I)
IDEA Tower 2, UPM-MDTC Technology Centre
Universiti Putra Malaysia
43400 Serdang, Selangor
Malaysia.

Phone: +603 8947 1622 | +6016 217 4050
Email: nayan@upm.my


Press release distributed by ResearchSEA for Pertanika Journal.


Aug 6, 2014 13:50 HKT/SGT
Topic: Research and development
Sectors: Science & Research, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Multimedia
Can probiotics reduce the severity of C. difficile infections?
View Image
 

Pertanika Journal
Dec 14, 2018 00:00 HKT/SGT
How to get the most fuel out of microalgae?
Dec 5, 2018 22:00 HKT/SGT
Better aquaculture management rewards Malaysia's fish farmers
Nov 27, 2018 08:00 HKT/SGT
Looking for ways to measure tumour aggression
Oct 2, 2018 19:30 HKT/SGT
Malaysian medicinal herb has anti-diabetic properties
Sept 25, 2018 19:00 HKT/SGT
Trees' species and age affect carbon emissions
Sept 5, 2018 18:00 HKT/SGT
Protecting rice plants by exploiting their natural defences
Aug 13, 2018 18:00 HKT/SGT
Too hot for rice?
Aug 2, 2018 23:00 HKT/SGT
Indonesian Sufism rejects radical Islam
Aug 1, 2018 09:00 HKT/SGT
Anti-ulcer benefits of honey investigated
June 20, 2018 10:00 HKT/SGT
Blood vessel-forming cells involved in aggressive brain tumour
More news >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: